Rangers send Evan Carter back to injured list, recall Cody Freeman

The Texas Rangers announced that outfielder Evan Carter has been placed back on the injured list after suffering a strained oblique. The move removes Carter from the club’s daily lineup and opens a roster vacancy that the Rangers have addressed by recalling infielder Cody Freeman.

Carter’s return to the injured list underscores how closely MLB teams monitor core and abdominal injuries, especially for hitters and defenders who rely on rotational strength. An oblique strain can affect timing at the plate, the ability to drive through contact, and a player’s comfort range in the outfield or on the bases, depending on severity and how quickly symptoms subside.

With Carter unavailable, the Rangers turned to their depth at the infield by elevating Freeman. Freeman’s recall is intended to stabilize the active roster while Texas navigates the period in which Carter is rehabbing rather than playing. The transaction also indicates that the Rangers view Freeman as capable of stepping into major league roles on short notice, whether that means providing infield coverage, contributing as a spot starter, or offering late-game flexibility.

For Rangers fans, the most immediate question is how long Carter’s absence could last and whether the oblique strain responds quickly enough for a return without setbacks. Teams often manage these situations cautiously because re-injury can be costly in timing and physical readiness, particularly when the stretch of the season tightens and lineup consistency matters.

The Freeman recall adds a different, but equally important, element to the roster picture. When a regular outfielder goes down, it is common to adjust the balance of the bench and defensive alignment. By recalling an infielder instead of making a more conventional outfield replacement, Texas is betting that Freeman’s skill set can cover the day-to-day needs created by Carter’s absence, at least in the near term.

Beyond the immediate roster logistics, the Carter injury creates a moving target for how the Rangers will structure their lineup and bullpen usage in his stead. When a player with established production and defensive value is sidelined, managers typically look for internal adjustments across positions and at-bats, while also protecting the rest of the regulars from overexertion. In the background, Texas also has to plan for how it will measure readiness during Carter’s rehab period, especially if symptoms fluctuate.

What to watch next is whether Texas provides additional updates on the oblique strain and how it handles Freeman’s role while Carter is out. If Freeman gets regular playing time, it could reveal how the Rangers want to weigh short-term needs against long-term roster development. And if Carter’s injury timeline shortens, the Rangers will need to be ready to integrate him back into the lineup smoothly, both physically and operationally.